Literature DB >> 28591524

Pembrolizumab for Advanced Urothelial Carcinoma.

Fei Liang1, Ji Zhu1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28591524     DOI： 10.1056/NEJMc1704612

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.

Authors:  Vikram Narayan; Andreas Kahlmeyer; Philipp Dahm; Nicole Skoetz; Michael C Risk; Connie Bongiorno; Neil Patel; Eu Chang Hwang; Jae Hung Jung; Gerald Gartlehner; Frank Kunath
Journal:  Cochrane Database Syst Rev       Date:  2018-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.